Lucy Boyle

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

<scp>NCRI</scp> phase <scp>II</scp> study of <scp>CHOP</scp> in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome

Toby A. Eyre, Ruth Clifford, Adrian Bloor et al. · British Journal of Haematology · 2016 · 66 citations

Pharmacy, Oncology, Pharmacotherapy +10

Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer

Esme J. Hill, Corran Roberts, Jamie Franklin et al. · Clinical Cancer Research · 2016 · 38 citations · Full text

Medicine, Oncology, Radiation Oncology +17

A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol

Shibani Nicum, Corran Roberts, Lucy Boyle et al. · BMC Cancer · 2014 · 10 citations · Full text

Medicine, Oncology, Pharmacology +15

Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter’s syndrome

Toby A. Eyre, Ruth Clifford, Corran Roberts et al. · BMC Cancer · 2015 · 10 citations · Full text

Medicine, Hematology, Oncology +17